Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to new research. The drugs — imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) — were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.